271 related articles for article (PubMed ID: 22587332)
1. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.
Gao W; He HW; Wang ZM; Zhao H; Lian XQ; Wang YS; Zhu J; Yan JJ; Zhang DG; Yang ZJ; Wang LS
Lipids Health Dis; 2012 May; 11():55. PubMed ID: 22587332
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
[TBL] [Abstract][Full Text] [Related]
3. Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.
Hopkins PN; Nanjee MN; Wu LL; McGinty MG; Brinton EA; Hunt SC; Anderson JL
Atherosclerosis; 2009 Dec; 207(2):559-66. PubMed ID: 19524242
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
[TBL] [Abstract][Full Text] [Related]
5. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
Hopkins PN; Wu LL; Hunt SC; Brinton EA
J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
[TBL] [Abstract][Full Text] [Related]
6. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age.
Martino F; Carlomosti F; Avitabile D; Persico L; Picozza M; Barillà F; Arca M; Montali A; Martino E; Zanoni C; Parrotto S; Magenta A
Clin Sci (Lond); 2015 Dec; 129(11):963-72. PubMed ID: 26229086
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated of SREBP-1 in circulating leukocyte is a risk factor for atherosclerosis: a case control study.
Peng C; Lei P; Li X; Xie H; Yang X; Zhang T; Cao Z; Zhang J
Lipids Health Dis; 2019 Oct; 18(1):177. PubMed ID: 31610782
[TBL] [Abstract][Full Text] [Related]
9. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
[TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
11. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
[No Abstract] [Full Text] [Related]
12. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
[TBL] [Abstract][Full Text] [Related]
13. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-208b and miR-499: Potential Biomarkers for Severity of Coronary Artery Disease.
Wang W; Li T; Gao L; Li Y; Sun Y; Yao HC
Dis Markers; 2019; 2019():9842427. PubMed ID: 31885748
[TBL] [Abstract][Full Text] [Related]
15. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
Qiu XK; Ma J
Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
[TBL] [Abstract][Full Text] [Related]
16. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
17. Correlation of trans fatty acids with the severity of coronary artery disease lesions.
Hadj Ahmed S; Kharroubi W; Kaoubaa N; Zarrouk A; Batbout F; Gamra H; Najjar MF; Lizard G; Hininger-Favier I; Hammami M
Lipids Health Dis; 2018 Mar; 17(1):52. PubMed ID: 29544473
[TBL] [Abstract][Full Text] [Related]
18. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.
Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT
Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091
[TBL] [Abstract][Full Text] [Related]
20. Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.
Simionescu N; Niculescu LS; Sanda GM; Margina D; Sima AV
Mol Biol Rep; 2014 Sep; 41(9):5765-73. PubMed ID: 24928089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
